RDHL insider trading — RedHill Biopharma Ltd.
Over the last 90 days, insiders at RedHill Biopharma Ltd. (RDHL) made 0 open-market purchases worth $0 and 1 open-market sale worth $1K, making them net sellers by $1K. The largest sale was by Raday Gilead (Chief Operating Officer), who sold 14,310,000 shares for $1K on Oct 1, 2026.
Updated Oct 16, 2026.
Recent RDHL insider transactions
Every Form 4 filed by RedHill Biopharma Ltd. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Raday Gilead | Chief Operating Officer | S · Sale | Direct | 14,310,000 | $0.00 | $1K | Form 4 |
RDHL insider trading FAQ
Are insiders buying RDHL stock?
Not on the open market. In the last 90 days, RedHill Biopharma Ltd. insiders made no open-market purchases, and 1 open-market sale totaling $1K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading RDHL?
Recent sellers: Raday Gilead.
Where does RDHL insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.